Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human studyYunlin Zhang, Marco Ruella, Luca Paruzzo et al.|Molecular Cancer|2023Cited by 32
CD45dimCD34+CD38−CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemiaSook‐Kyoung Heo, Jae‐Cheol Jo|BMC Cancer|2020Cited by 22
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell deathSook‐Kyoung Heo, Jae‐Cheol Jo|BMC Cancer|2020Cited by 12
Radotinib inhibits multiple myeloma cell proliferation via suppression of STAT3 signalingSook‐Kyoung Heo, Jae‐Cheol Jo|PLoS ONE|2022Cited by 11
The c-Abl inhibitor, radotinib induces apoptosis in multiple myeloma cells via mitochondrial-dependent pathwaySook‐Kyoung Heo, Jae‐Cheol Jo|Scientific Reports|2021Cited by 10